SHORT MINI-FUTURE - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 14:04:37 2024-05-21 EDT | ||
| 18.09 EUR | +2.73% |
|
| Current month | -6.22% | ||
| 1 month | -16.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 18.09 | +2.73% |
| 24-05-20 | 17.61 | -0.90% |
| 24-05-17 | 17.77 | -0.06% |
| 24-05-16 | 17.78 | +3.67% |
| 24-05-15 | 17.15 | -6.03% |
Delayed Quote Deutsche Boerse AG
Last update May 21, 2024 at 02:04 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VQ8L90 |
| ISIN | DE000VQ8L907 |
| Date issued | 2021-06-14 |
| Strike | 421.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.96 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 22.77 € |
|---|---|
| Lowest since issue | 1.71 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
227.7
USD
Average target price
285.9
USD
Spread / Average Target
+25.57%
- Stock Market
- Certificates
- Certificat
